BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  HuniLife Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting

  September 9, 2024

   · 

  1 min read
• Press Releases

  Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

  A new survey conducted by Quantum Research Group, LLC finds that more than half of patients diagnosed with sleep apnea are not satisfied with their current treatment. Nearly 70 percent of patients express a willingness to switch to a prescribed pill-form treatment.

  September 9, 2024

   · 

  4 min read
• Press Releases

  Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

  September 9, 2024

   · 

  7 min read
• Press Releases

  Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement

  September 9, 2024

   · 

  8 min read
• News

  Recovery First Treatment Center Launches Evening Virtual Treatment Program in English and Spanish, Expanding Access to Care

  September 9, 2024

   · 

  2 min read
• Drug Development

  OcuDyne Announces Positive Results for the OPTiC System™ 6-Month Clinical Trial in the Treatment of Geographic Atrophy

  September 9, 2024

   · 

  2 min read
• Press Releases

  Novo Nordisk A/S - share repurchase programme

  September 9, 2024

   · 

  2 min read
• Press Releases

  CorMedix Inc. Announces New Commercial Agreement

  September 9, 2024

   · 

  4 min read
• Press Releases

  Avanos Medical, Inc. to Present at the 2024 CL King Annual Best Ideas Conference

  September 9, 2024

   · 

  1 min read
• Press Releases

  Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide

  September 9, 2024

   · 

  8 min read